GlassScriptPhysician profile
Julie M Bilbrey
NPI 1609096643
$622.00
in general payments reported to CMS, 2019-2025
10 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.90 · 2022: $33.01 · 2023: $207 · 2024: $142 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $279.27 | 2023-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $90.66 | 2023-2025 | Shingrix, Arexvy |
| Pfizer INC. | $70.08 | 2022-2023 | |
| Amgen INC. | $43.51 | 2023-2024 | Prolia, Evenity |
| Inspire Medical Systems, INC. | $42.94 | 2025 | Inspire |
| Nevro Corp. | $23.47 | 2023 | Senza |
| Medtronic, INC. | $22.31 | 2025 | Venaseal |
| Boston Scientific Corporation | $21.39 | 2025 | Wavewriter Alpha Prime 16 |
| Sanofi Pasteur INC. | $14.90 | 2019 | |
| Dexcom, INC. | $13.47 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Bilbrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.